Hi all,
We are looking to gather insight on how different institutions standardize "protect from light" requirements for medications. Specifically:
- How are these requirements assessed and reviewed to ensure product labels are accurately reflected in the EMR/Apex?
- How frequently are these reviews conducted, and at what point in the drug approval or review process are these needs typically identified?
-How is “protect from light” defined in your policies/procedures/guidelines? Does it apply to storage, handling, reconstitution, and/or administration? If you are able, please provide a copy of your procedure/guideline.
Any input or examples from your systems would be greatly appreciated!
Thank you,
Sylvia Stoffella
UCSF Medical Center